Mazzarotto, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.377
AS - Asia 1.268
EU - Europa 507
SA - Sud America 364
Continente sconosciuto - Info sul continente non disponibili 65
AF - Africa 45
OC - Oceania 5
Totale 3.631
Nazione #
US - Stati Uniti d'America 1.306
SG - Singapore 487
BR - Brasile 297
CN - Cina 262
HK - Hong Kong 184
VN - Vietnam 122
IT - Italia 98
FR - Francia 73
DE - Germania 67
GB - Regno Unito 67
TR - Turchia 62
IE - Irlanda 45
RU - Federazione Russa 42
BD - Bangladesh 36
CA - Canada 34
IN - India 33
FI - Finlandia 28
AT - Austria 25
AR - Argentina 23
MX - Messico 18
EC - Ecuador 13
ZA - Sudafrica 13
CO - Colombia 12
IQ - Iraq 12
SE - Svezia 12
PK - Pakistan 11
JP - Giappone 10
MA - Marocco 8
VE - Venezuela 8
ES - Italia 7
UA - Ucraina 7
EG - Egitto 6
JM - Giamaica 6
PL - Polonia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 5
ID - Indonesia 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
GT - Guatemala 4
HN - Honduras 4
LT - Lituania 4
TH - Thailandia 4
AZ - Azerbaigian 3
BO - Bolivia 3
KR - Corea 3
NL - Olanda 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
AL - Albania 2
BE - Belgio 2
CL - Cile 2
CR - Costa Rica 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
NG - Nigeria 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.566
Città #
Singapore 246
Hong Kong 184
San Jose 136
Ashburn 134
The Dalles 99
Princeton 82
Lauterbourg 57
Los Angeles 53
Fairfield 51
Beijing 47
Istanbul 47
Council Bluffs 45
Dublin 43
Ho Chi Minh City 41
Columbus 38
Houston 32
São Paulo 30
Helsinki 28
Hanoi 25
Redondo Beach 25
New York 24
San Diego 24
Seattle 23
Dallas 22
San Francisco 20
Wilmington 19
Moscow 18
Nuremberg 16
Des Moines 15
Orem 14
Villa Carcina 14
Belo Horizonte 13
Brescia 13
London 13
Toronto 13
Ann Arbor 12
Buffalo 12
Vienna 12
Woodbridge 12
Atlanta 11
Milan 11
Santa Clara 11
Cambridge 10
Düsseldorf 9
Pontassieve 9
Stockholm 9
Chicago 8
Denver 8
Guangzhou 8
Montreal 8
Munich 8
Phoenix 8
Tianjin 8
Tokyo 8
Chennai 7
Curitiba 7
Dhaka 7
Manchester 7
Quito 7
Baghdad 6
Brasília 6
Charlotte 6
Mumbai 6
Portsmouth 6
Tashkent 6
Bremen 5
Brooklyn 5
Frankfurt am Main 5
Haiphong 5
Hải Dương 5
Johannesburg 5
Kyiv 5
Melbourne 5
Mexico City 5
Rio de Janeiro 5
Romola 5
Shanghai 5
Tampa 5
Thái Bình 5
Biên Hòa 4
Boston 4
Detroit 4
Fortaleza 4
Goiânia 4
Kilburn 4
Lahore 4
Mantova 4
Pittsburgh 4
Poplar 4
Sheffield 4
Uberlândia 4
Warsaw 4
Zurich 4
Algiers 3
Ankara 3
Boardman 3
Bogotá 3
Bologna 3
Buenos Aires 3
Caracas 3
Totale 2.104
Nome #
Genome-wide association testing beyond SNPs 130
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 94
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death 89
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 86
Comprehensive sequencing of dilated cardiomyopathy genes reveals additive effects of multiple genes on disease risk and severity 85
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy 85
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease 85
Ion channel dysfunction and fibrosis in atrial fibrillation: Two sides of the same coin 85
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 82
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy 82
Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning 80
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 79
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy 76
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies 76
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 76
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 73
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy 72
Comprehensive Assessment of Rare Genetic Variation in Dilated Cardiomyopathy Genes in Patients and Controls (vol 101, pg A41, 2015) 71
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 71
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect 71
Ion channel dysfunction and fubrosis in atrial fibrillation:Two sides of the same coin 70
EFFECTS OF TRUNCATING VARIANTS IN TITIN ON CARDIAC PHENOTYPE AND LEFT VENTRICULAR REMODELLING IN DILATED CARDIOMYOPATHY 69
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy 69
Quantifying evidence toward pathogenicity for rare phenotypes: the case of succinate dehydrogenase genes, SDHB and SDHD 68
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 67
CLINICAL AND GENETIC CHARACTERISTICS OF FAMILIAL DILATED CARDIOMYOPATHY IN A LARGE UK PROSPECTIVE COHORT 67
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 67
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies 66
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy 66
Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy 65
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 64
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples 63
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 61
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients with Hypertrophic Cardiomyopathy 59
FineSplice, enhanced splice junction detection and quantification: a novel pipeline based on the assessment of diverse RNA-Seq alignment solutions 59
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death 59
ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure 58
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy 58
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 57
Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions 57
Titin-truncating variants affect heart function in disease cohorts and the general population 56
INTEGRATED ALLELIC, TRANSCRIPTIONAL, AND PHENOTYPIC DISSECTION OF THE CARDIAC EFFECTS OF TITIN VARIATION IN HEALTH AND DISEASE 56
Two decades of genetic testing in hypertrophic cardiomyopathy in a single center: The additive value of extended next-generation sequencing panels lies in the early diagnosis of metabolic mimics 55
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases 55
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation 54
Temporal Trend in Age at Diagnosis of Hypertrophic Cardiomyopathy: An Analysis of the Share Registry 53
Genetic ancestry analysis of the Italian founder population carrying the cardiac amyloidosis-causing variant Val122Ile in the transthyretin gene 53
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy 53
Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy 52
Temporal trend in age at diagnosis of hypertrophic cardiomyopathy: an analysis of the share registry 52
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 49
RE-EVALUATING THE GENETIC CONTRIBUTION OF MONOGENIC DILATED CARDIOMYOPATHY 47
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 46
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 33
Totale 3.631
Categoria #
all - tutte 28.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022203 0 16 2 6 0 18 46 8 13 2 13 79
2022/2023107 41 0 1 4 1 42 2 0 6 9 1 0
2023/2024201 1 2 15 15 5 5 5 4 99 2 0 48
2024/2025845 1 6 6 85 88 49 71 84 80 97 183 95
2025/20262.012 191 266 155 322 174 128 273 104 137 139 87 36
2026/2027136 84 52 0 0 0 0 0 0 0 0 0 0
Totale 3.631